Spectrum Pharmaceutecals Inc (SPPI)

[muchogusto]

Antihama, you said "With pozi, if we have to wait for the EU patients to recruit and mature before they submit a NDA, that would take us to 2022-2023 timeframe to see pozi revenue (but unlike Rolontis, pozi would see an immediate uplift in sales due to it treating an unmet medical need). So w pozi, it would benefit the share price greatly if SPPI could give us their regulatory thinking that would speed up that 2022-2023 timeline that one has to assume right now. ". Is this Pozi timeline something that has come to light just recently or it has been the case all along? I am just trying to understand whether you meant this as something that is causing the selloff? By the way we are making new 12 month lows in the last few days!